New Therapeutic Approaches in Cystic Fibrosis

A Review of Oral Submucousal Fibrosis, Related Factors, Prognosis and New Therapeutic Approaches

Abstract   BACKGROUNackground and AIMD & AIM: Oral Submucous Fibrosis (OSF) is an oral premalignant condition with highest premalignant potential  among oral precancerous lesions which characterized with inflammation and  progressive fibrosis of  submucosal oral tissues (cause to significant irreversible rigidity and trismus). During the years, many classification systems have been propo...

new treatment approaches of pseudomonas aeruginosa infection in cystic fibrosis lung disease

Maintaining Respiratory Health in Cystic Fibrosis Patients

Cystic fibrosis (CF) is an inherited disease that primarily affects the lungs and the digestive system, however, it also affects a number of other organs and systems. More than 90% of mortality of  CF patients is due to lung complications.  Healthy lungs are important for a long life for people with CF, We will discuss two important topics for maintaining respiratory health. Chronic use of drug...

Cystic Fibrosis: Therapeutic Options For Co-management

Cystic fibrosis (CF) is a cruel and deadly disease affecting the respiratory system, digestive system, endocrine system, and reproductive system. CF is a disease of greatly varied symptomatology due to the many possible mutations contributing to genotype and phenotype. This creates a disease complex with a wide range of disorders that can ultimately include chronic obstructive pulmonary disease...

Cystic fibrosis: molecular approaches to diagnosis.

Whole blood collected on filter paper (Guthrie cards) has provided an excellent means for screening inborn errors of metabolism in neonates. Traditional biochemical methods adapted for use with this collection device have proven instrumental in the detection of many congenital defects such as phenylketonuria, galactosemia, hypothyroidism and hemoglobinopathies. The advent of molecular technique...